bifendate has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, G; Liu, Z; Zhang, S | 1 |
| Cui, Q; Liu, GT; Liu, ZY | 1 |
2 other study(ies) available for bifendate and Liver Neoplasms
| Article | Year |
|---|---|
[Reversing effect of dimethyl-4,4'-dimethoxy-5,6,5'6'-dimethylenedioxybiphenyl-2,2'- dicarboxylate(DDB) on the phenotypes of human hepatocarcinoma cell line].
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Dioxoles; Drugs, Chinese Herbal; gamma-Glutamyltransferase; Genes, myc; Genes, p53; Humans; Liver Neoplasms; Tumor Cells, Cultured | 1995 |
[Effect of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2, 2'-dicarboxylate (DDB) on several phenotypes of Bel-7402 hepatocarcinoma cell line and its mechanism].
Topics: Antineoplastic Agents; Calmodulin; Carcinoma, Hepatocellular; Cyclic AMP; Dioxoles; DNA Topoisomerases, Type II; Humans; Liver Neoplasms; Phenotype; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1996 |